Core Viewpoint - The integration of traditional Chinese medicine (TCM) with Western medicine is gaining popularity internationally, with many foreign patients seeking TCM treatments such as herbal medicine and acupuncture, which have shown effective results [1][2]. Group 1: Event Overview - The second Maritime Silk Road Traditional Chinese Medicine Culture Forum was held in Zhangzhou, Fujian, focusing on the themes of TCM inheritance, innovation, and integration [2]. - The forum gathered TCM experts and scholars from both domestic and international backgrounds to discuss the development of TCM [2]. Group 2: Key Projects and Agreements - A total of 47 projects were signed during the forum, with a total investment amounting to 154.47 billion yuan [4][6]. - The projects included 18 health industry projects with an investment of 61.55 billion yuan, 22 fund establishment and attraction projects totaling 92.92 billion yuan, and 7 technology achievement transformation projects [6]. Group 3: Local Significance and Initiatives - Zhangzhou is recognized as an important node in the Maritime Silk Road and has a rich history in traditional medicine, with notable historical figures and renowned medicines originating from the area [5]. - The city is implementing the "Yuan Mountain Plan," which aims to enhance the integration of TCM and health industries across the Taiwan Strait, promoting TCM culture and innovation [5].

Core Insights - The Hansa Mei'an Traditional Chinese Medicine Center in Hamburg celebrated its 15th anniversary, marking significant achievements in research, education, clinical practice, and international collaboration, serving as a model for the development of TCM in the European healthcare system [1][2] Group 1: Establishment and Achievements - The Hansa Mei'an TCM Center was established in 2010 as the first specialized TCM institution within the German university hospital system [1] - Over the past 15 years, the center has served more than 30,000 patients and published approximately 70 academic papers in international journals, gaining attention from the global medical community [2] Group 2: Cultural and Collaborative Impact - The establishment of the center reflects the fruitful relationship between Shanghai and Hamburg, symbolizing practical cooperation between China and Germany [1] - Research is deemed crucial for the development of TCM in Europe, with ongoing collaborations between TCM research institutions in Hamburg, Shanghai, and Hefei showing steady progress [1] Group 3: Future Focus - The center aims to continue focusing on the integration of Chinese and Western medicine, international standardization, and the cultivation of cross-cultural medical talent [1]

Core Insights - The QUEST study, which evaluates the efficacy of traditional Chinese medicine Qiliqiangxin capsules in treating chronic heart failure, has been recognized as one of the top ten research advancements in cardiovascular disease for 2024 [1][4]. Group 1: Study Overview - The QUEST study is the first hard endpoint study in China focusing on traditional Chinese medicine for chronic heart failure, demonstrating a 22% reduction in the risk of major composite endpoint events compared to the control group [4]. - The study also reported a 24% reduction in the risk of heart failure exacerbation leading to rehospitalization and a 17% reduction in cardiovascular mortality, indicating the treatment's safety and good tolerability [4]. Group 2: Subgroup Analyses - Subgroup analyses revealed that Qiliqiangxin capsules have minimal impact on blood pressure and provide clinical benefits for heart failure with reduced ejection fraction (HFrEF) patients, regardless of baseline systolic blood pressure [5]. - The analysis of NT-ProBNP levels showed that Qiliqiangxin significantly lowers plasma NT-proBNP levels in HFrEF patients, demonstrating consistent tolerability across different baseline NT-proBNP levels [5]. - The analysis regarding left ventricular ejection fraction (LVEF) indicated that the benefits of Qiliqiangxin in reducing cardiovascular events are consistent across various LVEF levels, with more significant absolute benefits observed in patients with low LVEF [6]. Group 3: Implications for Traditional Chinese Medicine - The inclusion of the QUEST study in the top ten advancements highlights the scientific value of traditional Chinese medicine in modern medical research and offers new treatment options for patients with reduced ejection fraction heart failure [6]. - The ongoing promotion and application of the study's findings may lead to significant advancements in cardiovascular disease management in China, showcasing the potential of integrating traditional and modern medicine [6].

Core Viewpoint - The integration of Traditional Chinese Medicine (TCM) and Western Medicine (WM) is essential for enhancing patient care and treatment outcomes, as both have unique strengths that can complement each other [1][2][3] Group 1: Current Developments - Recent years have seen significant advancements in the integration of TCM and WM, including the establishment of national centers and educational programs focused on this combined approach [2][3] - The formation of a national alliance of 62 top-tier hospitals aims to enhance clinical capabilities and academic standards in TCM-WM integration through collaborative efforts [3] Group 2: Challenges and Opportunities - Despite progress, the phenomenon of TCM and WM operating in silos remains prevalent in higher education and clinical practice, hindering effective integration [2] - There is a need for improved evaluation systems for TCM-WM integration and better career advancement opportunities for practitioners in this field [2][3] Group 3: Future Directions - The focus should be on achieving organic integration of TCM and WM, emphasizing efficacy and breaking down existing institutional barriers [3] - Historical context highlights that the integration of TCM and WM has been a long-term goal, with recent policy frameworks supporting this direction [3]

Core Viewpoint - The release of the first expert consensus on the cardiovascular event chain provides a Chinese characteristic clinical drug treatment plan that integrates traditional Chinese medicine and Western medicine, aiming to systematically intervene in cardiovascular diseases [1][2][3] Group 1: Expert Consensus Overview - The expert consensus titled "Expert Consensus on Systematic Intervention of Cardiovascular Event Chain with Tongluo Drugs" was published during the 12th Chinese Association of Integrative Medicine Vascular Disease Conference [1] - The consensus addresses the need for new intervention methods for the cardiovascular event chain, which is characterized by a series of events leading to severe outcomes such as myocardial infarction and heart failure [1] Group 2: Mechanisms and Clinical Evidence - The consensus includes a series of Tongluo drugs (e.g., Jinlida granules, Tongxinluo capsules) and their mechanisms and clinical evidence for intervening in diseases related to the cardiovascular event chain, such as diabetes, stroke, coronary heart disease, arrhythmia, and heart failure [2] - Significant clinical evidence from national key research projects supports the breakthroughs in traditional Chinese medicine, including the prevention of type 2 diabetes and improvements in coronary plaque stability [2] Group 3: Impact and Future Prospects - The consensus is expected to enhance the prevention and treatment of cardiovascular diseases, significantly reducing their incidence and mortality rates [3] - The release of the consensus is anticipated to attract global attention to traditional Chinese medicine and stimulate further research in the integration of traditional and modern medical practices [3]

Core Viewpoint - The article highlights the recognition of ten exemplary doctors in China, emphasizing their dedication to medical ethics, patient care, and innovative practices in their respective fields [1]. Group 1: Recognition of Exemplary Doctors - Ten doctors were honored as the "Most Beautiful Doctors" for their commitment to medical ethics and patient care [1]. - The report focuses on their inspiring stories and contributions to healthcare, showcasing their dedication to life and health [1]. Group 2: Individual Contributions - Wang Yufeng, a pediatric psychiatrist, has significantly impacted children's mental health, treating many patients late into the night due to high demand [2][3]. - He Jianxing, a thoracic surgeon, has pioneered a minimally invasive lung cancer surgery technique, performing nearly 20,000 surgeries over 40 years [3][4]. - Ni Ma La Mao, a doctor in a remote area, provides essential healthcare services despite challenging conditions, often traveling long distances to reach patients [5][6]. - Liang Chunrong, a village doctor, has dedicated over 30 years to serving his community, emphasizing accessible healthcare regardless of patients' financial situations [6][7]. - Zhou Jianhong, a gynecologist, focuses on women's health education, particularly in rural areas, and has established a health awareness initiative [8]. - Shen Xiaohui, a hematologist, has advanced the field of blood diseases through innovative treatments and the integration of traditional Chinese medicine [9].

Core Viewpoint - The article discusses the impact of fluctuating spring weather on respiratory health and emphasizes the importance of scientific medication approaches to combat influenza, highlighting the integration of traditional Chinese medicine and Western medicine in treatment strategies [1][4]. Group 1: Influenza Treatment Mechanisms - Current mature antiviral drugs primarily operate through two mechanisms: directly targeting influenza virus nucleic acids to destroy the virus structure and inhibiting the release and spread of the virus [2]. - The traditional Chinese medicine Lianhua Qingwen has a modern medical interpretation of its antiviral mechanisms, combining historical medical practices and modern pharmacological research [2]. Group 2: Efficacy of Lianhua Qingwen - Pharmacological studies indicate that Lianhua Qingwen exhibits broad-spectrum antiviral effects against various viruses, including H1N1, H3N2, and other respiratory viruses, showing significant inhibition [2]. - Clinical research demonstrates that Lianhua Qingwen can promote the negative conversion of viral nucleic acids in patients with influenza and is more effective in alleviating symptoms such as fever, cough, sore throat, and fatigue [2]. Group 3: Integration of Traditional and Western Medicine - The integration of traditional Chinese medicine and Western medicine provides more treatment options for influenza, with ongoing national policies promoting this development [4]. - There is a need for further foundational research and clinical practice to explore more effective treatment strategies combining both medical approaches [4].

Core Viewpoint - Shenzhen Traditional Chinese Medicine Anorectal Hospital (Futian) officially opened its Meilin branch on March 25, marking a significant milestone in the hospital's development and a new journey for traditional Chinese medicine in the anorectal field in Shenzhen [1] Group 1: Hospital Development History - The hospital was founded in 1998 by Du Kuyi, a fourth-generation inheritor of the "Du's Anorectal" intangible cultural heritage, and has evolved into a key center for anorectal disease treatment in Shenzhen [2] - In 2017, the establishment of the "Shenzhen Futian District Anorectal Specialty Hospital" was approved, marking the beginning of specialized anorectal medical services in Futian [2] - The hospital was officially renamed "Shenzhen Traditional Chinese Medicine Anorectal Hospital (Futian)" in 2018, emphasizing the integration of traditional Chinese medicine and anorectal specialties [2][3] Group 2: New Hospital Features - The new Meilin branch covers a total construction area of 70,283 square meters, which is over 15 times larger than the old site, increasing the number of beds from 130 to 420 and expanding the number of wards from 4 to 11 [4] - The hospital has invested in advanced medical equipment, with 390 sets valued at 150 million yuan, enhancing its medical capabilities and service quality [4] - The design and construction of the new hospital adhere to the principles of "people-centered" healthcare, aiming to create a modernized specialty hospital that integrates traditional Chinese medicine with modern technology [4] Group 3: Talent Development - The hospital emphasizes talent cultivation and recruitment, aiming to build an international high-quality medical team, with 34 senior title experts and 12 doctors holding doctoral degrees [5] - The hospital has established a positive work environment to enhance staff cohesion and has implemented comprehensive incentive and promotion mechanisms for career development [6] Group 4: Future Outlook - The hospital aims to achieve "two A" hospital status soon after relocating and plans to become a "three A" specialty hospital in the coming years [7] - It will focus on optimizing medical service processes and enhancing service quality to provide better healthcare for patients, while also exploring AI-assisted traditional Chinese medicine applications [7] - The hospital seeks to establish itself as a health landmark in the Guangdong-Hong Kong-Macao Greater Bay Area, providing integrated health services [7][8]